Qiming Venture Partners USA is a venture capital firm that invests in early-stage healthcare and technology companies in the United States.

Qiming Venture Partners USA

We know how companies can and should be built.

Founded in 2017, Qiming Venture Partners USA is a healthcare venture capital firm and healthcare investor with a combination of deep technical expertise that allows us to identify tomorrow’s innovations early and strong operational experience with a hands-on approach that makes us the investor of choice for early-stage biotech companies.

Our partners often are sought-after to be on company boards because of their proven, hands-on approach to supporting CEOs and scaling operations. They are trusted business and thought partners.

All of our partners have worked and lived outside of the US, providing us with a true global mindset and our networks are extensive. Only Qiming Venture Partners USA can offer exclusive access and synergy to China, the second-largest healthcare market in the world. We have a unique ability to leverage a world-class China and broader Asian network for market diligence, deal flow, and operational support for portfolio companies.

We harness the deep and highly accretive backgrounds and skillsets of our founders with a next-generation approach through our partners to understand tomorrow’s innovations and reaching across a wide variety of crossover and public investors.

Elevation Oncology

Satellos Bioscience

Talaris Therapeutics

Ventyx Biosciences

HilleVax

Icosavax

Jasper Therapeutics

Congratulations to Umoja Biopharma on their groundbreaking partnership with AbbVie to advance development of in vivo CAR-T therapies for patients in need.

Umoja's VivoVec + RACR/CAR technology enables CAR-T transduction to occur directly in the patient while avoiding challenging chemotherapeutic lymphodepletion regimens, overcoming sizable patient access + manufacturing challenges faced with autologous CAR-T therapies, which are created outside the body. 

Today, we are one significant step closer to a world where more patients, in a safer manner, could be eligible to receive potentially disease-curative medicines. This is made possible by Umoja's outstanding drug development expertise and catalyzed by their state of the art manufacturing capabilities at the CLIMB.

Hearty congrats to the Icosavax, Inc. team on positive data for bivalent RSV / hMPV vaccine and subsequent transaction to AstraZeneca!

https://lnkd.in/gv_x9cZU

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 1, 2024 3:02 PM	730d85f9
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Sep 1, 2024 3:02 PM	aa777c06
translate crunchbase fundingrounds	general
peers	general	Sep 1, 2024 3:02 PM	c62be1f2
news basic	general	Sep 1, 2024 3:02 PM	8794c830
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:QIMINGVCUSA

Qiming Venture Partners USA